Physician profile
Christopher H Chon
NPI 1861427445
$8,997.52
in general payments reported to CMS, 2019-2025
7 companies · $905 in 2025
The $905 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $34.93 · 2022: $1,614 · 2023: $4,019 · 2024: $2,229 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,599 · Food and Beverage: $1,531 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,598.77 |
| Food and Beverage | $1,531.24 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,128.43 | 2022-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $2,548.20 | 2019-2025 | Lithovue, Moses 550 D\F\L |
| Teleflex LLC | $128.52 | 2024 | Urolift |
| Glaxosmithkline, LLC. | $123.11 | 2024 | Arexvy, Shingrix |
| Laborie Medical Technologies Corp. | $36.67 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $17.63 | 2024 | |
| Ethicon US, LLC | $14.96 | 2023 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.